» Articles » PMID: 36934744

Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma

Abstract

Significance: Multispectral near-infrared I/shortwave infrared fluorescence imaging is a versatile system enabling high tumor-to-background signal for safer and more complete resection of pediatric tumors during surgery.

Citing Articles

Systematic comparison of fluorescence imaging in the near-infrared and shortwave-infrared spectral range using clinical tumor samples containing cetuximab-IRDye800CW.

Keizers B, Nijboer T, van der Fels C, van den Heuvel M, van Dam G, Kruijff S J Biomed Opt. 2024; 30(Suppl 1):S13708.

PMID: 39553388 PMC: 11566260. DOI: 10.1117/1.JBO.30.S1.S13708.


Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging.

Tian Y, Shen H, Li L, Jia X, Liu J, Hu Z Eur J Nucl Med Mol Imaging. 2024; 51(9):2569-2582.

PMID: 38647671 DOI: 10.1007/s00259-024-06714-w.


Monoclonal Antibodies for Targeted Fluorescence-Guided Surgery: A Review of Applicability across Multiple Solid Tumors.

Giuliani S, Paraboschi I, McNair A, Smith M, Rankin K, Elson D Cancers (Basel). 2024; 16(5.

PMID: 38473402 PMC: 10931077. DOI: 10.3390/cancers16051045.


A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [Cu]Cu-NOTA-ch14.18/CHO.

Trautwein N, Schwenck J, Seitz C, Seith F, Calderon E, von Beschwitz S Theranostics. 2024; 14(3):1212-1223.

PMID: 38323317 PMC: 10845206. DOI: 10.7150/thno.92481.


Machine Learning-Assisted Short-Wave InfraRed (SWIR) Techniques for Biomedical Applications: Towards Personalized Medicine.

Salimi M, Roshanfar M, Tabatabaei N, Mosadegh B J Pers Med. 2024; 14(1).

PMID: 38248734 PMC: 10817559. DOI: 10.3390/jpm14010033.


References
1.
Park J, Eggert A, Caron H . Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am. 2010; 24(1):65-86. DOI: 10.1016/j.hoc.2009.11.011. View

2.
Fisher J, Flutter B, Wesemann F, Frosch J, Rossig C, Gustafsson K . Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells. Oncoimmunology. 2016; 5(1):e1025194. PMC: 4760299. DOI: 10.1080/2162402X.2015.1025194. View

3.
Zhu S, Yung B, Chandra S, Niu G, Antaris A, Chen X . Near-Infrared-II (NIR-II) Bioimaging Off-Peak NIR-I Fluorescence Emission. Theranostics. 2018; 8(15):4141-4151. PMC: 6096392. DOI: 10.7150/thno.27995. View

4.
Hagenbuch B . Drug uptake systems in liver and kidney: a historic perspective. Clin Pharmacol Ther. 2009; 87(1):39-47. PMC: 2819296. DOI: 10.1038/clpt.2009.235. View

5.
Nazha B, Inal C, Owonikoko T . Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy. Front Oncol. 2020; 10:1000. PMC: 7358363. DOI: 10.3389/fonc.2020.01000. View